ArticleJournal of fluorescence2026
Design, Synthesis, and Fluorescence Properties of Bis-Schiff Base Derivatives Via Spectroscopic, Computational, and Docking Approaches.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study emphasises the Synthesis of novel bis-Schiff base derivatives via the condensation reaction of two different aldehydes with a aromatic diamine. This reaction was carried out between p-phenylenediamine with 4-chlorobenzaldehyde and 2,4-dichlorobenzaldehyde. The study will explain the structural comparison between the compound PP4CLB and PP24CLB. The synthetic compounds' configurations were verified by DFT calculations, and their structural integrity was verified by NMR, Raman, and IR spectroscopy. To provide a detailed characterisation of molecular properties, the study included a wide range of analyses, such as the assessment of molecular electrostatic potential, frontier molecular orbitals, and HOMO-LUMO energy gaps. For our molecular docking analysis, we used the Tdp1 catalytic domain in complex with an inhibitor (PDB ID: 6W7J) protein as the target. Both PP4CLB and PP24CLB used the same protein structure. The docking results indicated that PP24CLB demonstrated a marginally superior binding affinity (-8.03 kcal/mol) relative to PP4CLB (-7.89 kcal/mol). The interaction analysis showed that both ligands made several stabilising connections in the active site of 6W7J. PP24CLB had two hydrogen bonds and other non-covalent interactions. On the other hand, PP4CLB had other non-covalent interactions. The PASS prediction showed that our compound is very likely to have biological activity, with a Pa value of 0.849. This Pa score means that the compound is very likely to work as a Glycosylphosphatidylinositol phospholipase D (GPI-PLD) inhibitor.
Indexed as
Identifiers
41462009What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.